Clinically, interferon has led to the development of many side effects and potentially toxic at high doses, especially when registered with multiple different treatments.33 34 While the doses of IFNβ and Alb-IFNβ used in this study were low and all tumor-bearing mice were only treated twice, there may still be toxicity concerns. The gene discussed is IFNB1; the disease is neoplasm.